156 related articles for article (PubMed ID: 28926513)
1. Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.
Hernandez G; Zhao L; Franke AA; Chen YL; Mack WJ; Brinton RD; Schneider LS
Menopause; 2018 Feb; 25(2):191-196. PubMed ID: 28926513
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.
Wang Y; Hernandez G; Mack WJ; Schneider LS; Yin F; Brinton RD
Menopause; 2020 Jan; 27(1):57-65. PubMed ID: 31567873
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.
Yao J; Zhao L; Mao Z; Chen S; Wong KC; To J; Brinton RD
Brain Res; 2013 Jun; 1514():128-41. PubMed ID: 23428542
[TBL] [Abstract][Full Text] [Related]
4. Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.
Schneider LS; Hernandez G; Zhao L; Franke AA; Chen YL; Pawluczyk S; Mack WJ; Brinton RD
Menopause; 2019 Aug; 26(8):874-884. PubMed ID: 30889096
[TBL] [Abstract][Full Text] [Related]
5. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
6. Phytoestrogens Activate the Estrogen Receptor in HepG2 Cells.
Kelly LA
Methods Mol Biol; 2016; 1366():445-455. PubMed ID: 26585156
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogens.
Kelly LA; Seidlova-Wuttke D; Wuttke W; O'Leary JJ; Norris LA
Phytomedicine; 2014 Jan; 21(2):155-8. PubMed ID: 23972791
[TBL] [Abstract][Full Text] [Related]
8. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women.
Anupongsanugool E; Teekachunhatean S; Rojanasthien N; Pongsatha S; Sangdee C
BMC Clin Pharmacol; 2005 Mar; 5():2. PubMed ID: 15743537
[TBL] [Abstract][Full Text] [Related]
10. Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.
Jackson RL; Greiwe JS; Schwen RJ
Nutr Rev; 2011 Aug; 69(8):432-48. PubMed ID: 21790611
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
13. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.
Setchell KD; Clerici C; Lephart ED; Cole SJ; Heenan C; Castellani D; Wolfe BE; Nechemias-Zimmer L; Brown NM; Lund TD; Handa RJ; Heubi JE
Am J Clin Nutr; 2005 May; 81(5):1072-9. PubMed ID: 15883431
[TBL] [Abstract][Full Text] [Related]
14. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.
Setchell KD; Zhao X; Jha P; Heubi JE; Brown NM
Am J Clin Nutr; 2009 Oct; 90(4):1029-37. PubMed ID: 19710188
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women.
Setchell KD; Zhao X; Shoaf SE; Ragland K
J Nutr; 2009 Nov; 139(11):2037-43. PubMed ID: 19776178
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of phytoestrogens on protein turnover in rainbow trout (Oncorhynchus mykiss) white muscle.
Cleveland BM
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Sep; 165():9-16. PubMed ID: 24874080
[TBL] [Abstract][Full Text] [Related]
18. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor β-agonist being developed for the treatment of menopausal symptoms.
Jackson RL; Greiwe JS; Desai PB; Schwen RJ
Menopause; 2011 Feb; 18(2):185-93. PubMed ID: 21341397
[TBL] [Abstract][Full Text] [Related]
19. Roles of Phytoestrogen in the Pathophysiology of Intracranial Aneurysm.
Yokosuka K; Rutledge C; Kamio Y; Kuwabara A; Sato H; Rahmani R; Purcell J; Eguchi S; Baranoski JF; Margaryan T; Tovmasyan A; Ai J; Lawton MT; Hashimoto T
Stroke; 2021 Aug; 52(8):2661-2670. PubMed ID: 34157864
[TBL] [Abstract][Full Text] [Related]
20. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
